Treatment of obesity type 1 diabetes with Dapagliflozin:a case report / 中国糖尿病杂志
Chinese Journal of Diabetes
; (12): 133-136, 2024.
Article
de Zh
| WPRIM
| ID: wpr-1025162
Bibliothèque responsable:
WPRO
ABSTRACT
As a new hypoglycemic drug,Dapagliflozin has attracted much attention because of its unique hypoglycemic mechanism. It has been used in many studies on type 2 diabetes mellitus,but the application of type 1 diabetes mellitus(T1DM)in the eastern population is rare. This article uses Dapagliflozin through a case of obese T1DM to provide new ideas for the treatment of T1DM.
Texte intégral:
1
Indice:
WPRIM
langue:
Zh
Texte intégral:
Chinese Journal of Diabetes
Année:
2024
Type:
Article